Mucopolysaccharidosis type IIIA (MPS IIIA) Treatment Market 2030
The global Mucopolysaccharidosis type IIIA (MPS IIIA) Treatment Market size was valued at USD 231.3 million in 2023 and is expected to grow at a 4.9% CAGR from 2024 to 2030. It also includes market size and projection estimations for each of the five major regions from 2024 to 2030. The research report includes historical data, trending features, and market growth estimates for the future....
0 Comments 0 Shares 1K Views 0 Reviews